Exact Mass: 890.1939202000001
Exact Mass Matches: 890.1939202000001
Found 13 metabolites which its exact mass value is equals to given mass value 890.1939202000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,3-diene-Valproic acid-CoA
2,3-diene-Valproic acid-CoA is a metabolite of valproic acid. Valproic acid (VPA) is a chemical compound and an acid that has found clinical use as an anticonvulsant and mood-stabilizing drug, primarily in the treatment of epilepsy, bipolar disorder, and, less commonly, major depression. It is also used to treat migraine headaches and schizophrenia. VPA is a liquid at room temperature, but it can be reacted with a base such as sodium hydroxide to form the salt sodium valproate, which is a solid. (Wikipedia)
Epiafzelechin-(2beta->7,4beta->8)-epiafzelechin-(4beta->8)-dryopteric acid
4-acetamidobutanoyl-CoA(4-)
An acyl-CoA(4-) species arising from deprotonation of the phosphate and diphosphate OH groups of 4-acetamidobutanoyl-CoA; major species at pH 7.3.
(10r,11r,12r,13s,15r)-13-{3,5-dihydroxy-4-[3-(4-hydroxyphenyl)propanoyl]phenoxy}-3,4,5,12,21,22,23-heptahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-11-yl 3,4,5-trihydroxybenzoate
13-{3,5-dihydroxy-4-[3-(4-hydroxyphenyl)propanoyl]phenoxy}-3,4,5,12,21,22,23-heptahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-11-yl 3,4,5-trihydroxybenzoate
[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-7-yl]-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid
6-[(4a-{[9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C40H42O21S (890.1939202000001)
[(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(1r,5r,6r,7s,13s,21r)-6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-7-yl]-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid
(2r,3r,4r,5s,6r)-6-{[(1s,3s,4as,10ar)-4a-{[(1s,3s,4as,10ar)-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-8-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
C40H42O21S (890.1939202000001)